PMID- 3190366 OWN - NLM STAT- MEDLINE DCOM- 19881221 LR - 20061115 IS - 0020-3785 (Print) VI - 58 IP - 4 DP - 1988 Jul-Aug TI - [Importance of the early intravenous administration of streptokinase in acute myocardial infarct]. PG - 307-11 AB - To evaluate the importance of early initiation of fibrinolytic therapy with intravenous streptokinase (IVSK), we studied 34 consecutive patients, within less than six hours of the onset of acute myocardial infarction, who were treated with 1.5 million units of intravenous streptokinase. All the patients had coronary angiograms in the first seventy two hours. We correlated the angiograms with the time of onset of the IVSK. The patients were divided into 3 groups: Group num. 1: From zero to two hours (twelve patients); Group num. 2: From two to four hours (13 patients); and Group num. 3: From four to six hours (nine patients). We had angiographic reperfusion in twenty-four patients (70.2%) P less than 0.05. We observed reopening in the patients of group num. 1 (83.3%); in group 2, nine patients (69%) and in group num. 3, five patients, (55.5%), with statistical significance only in group num. 1 (p less than 0.05). We also demonstrated the utility of the electrocardiographic and enzymatic criteria to predict reperfusion. No mortality was related to the procedure. We concluded that a higher percentage of reperfusion is obtained the sooner intravenous streptokinase therapy is initiated. FAU - Martinez Rios, M A AU - Martinez Rios MA AD - Instituto Nacional de Cardiologia, Ignacio Chavez, Mexico, D.F. FAU - Levy, J AU - Levy J FAU - Gil Moreno, M AU - Gil Moreno M FAU - Ojeda, J L AU - Ojeda JL FAU - Garcia, P AU - Garcia P FAU - Cardenas, M AU - Cardenas M FAU - Soni, J AU - Soni J LA - spa PT - English Abstract PT - Journal Article TT - Importancia del inicio precoz en la administracion de estreptoquinasa intravenosa en el infarto agudo del miocardio. PL - Mexico TA - Arch Inst Cardiol Mex JT - Archivos del Instituto de Cardiologia de Mexico JID - 0400463 RN - EC 3.4.- (Streptokinase) SB - IM MH - Coronary Circulation/*drug effects MH - Humans MH - Injections, Intravenous MH - Myocardial Infarction/*drug therapy/physiopathology MH - Streptokinase/administration & dosage/pharmacology/*therapeutic use MH - Time Factors EDAT- 1988/07/01 00:00 MHDA- 1988/07/01 00:01 CRDT- 1988/07/01 00:00 PHST- 1988/07/01 00:00 [pubmed] PHST- 1988/07/01 00:01 [medline] PHST- 1988/07/01 00:00 [entrez] PST - ppublish SO - Arch Inst Cardiol Mex. 1988 Jul-Aug;58(4):307-11.